Early detection is the key to
breast cancer survival
Beating the odds on breast cancer!
OncoVue is a powerful tool to assess a woman's genetic risk for breast cancer. The OncoVue assessment helps the doctor and patient decide on the level of surveillance and diagnostic testing necessary to detect breast cancer early.
A big difference
The survival rate for early detection is 97%. The survival rate for breast cancer detected later drops to 21%.
Breast cancer detected early can be discovered so small it can be treated in one day in the office setting without surgery, chemotherapy or radiation treatment.
Is this worth doing?
Ask your doctor if OncoVue
is right for you.
OncoVue
- saliva test
- no exam required
- covered by insurance plans
- discrimination in health insurance
and employment prohibited by law